Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Cellular transcriptomics: gelsolin negatively regulates the expression of apoptosis-associated genes and inhibits apoptosis in hepatocarcinoma cells.

Zhou Y, Deng X, Ma X, Zang N, Li H, Li G, Li D, Li C, Huang W, He M.

Int J Clin Exp Pathol. 2015 Nov 1;8(11):13871-85. eCollection 2015.

2.

A survey of best practices for RNA-seq data analysis.

Conesa A, Madrigal P, Tarazona S, Gomez-Cabrero D, Cervera A, McPherson A, Szcześniak MW, Gaffney DJ, Elo LL, Zhang X, Mortazavi A.

Genome Biol. 2016 Jan 26;17(1):13. doi: 10.1186/s13059-016-0881-8.

3.

The structure and function of NKAIN2-a candidate tumor suppressor.

Zhao SC, Zhou BW, Luo F, Mao X, Lu YJ.

Int J Clin Exp Med. 2015 Oct 15;8(10):17072-9. eCollection 2015. Review.

4.

The Molecular Taxonomy of Primary Prostate Cancer.

Cancer Genome Atlas Research Network. Electronic address: schultz@cbio.mskcc.org; Cancer Genome Atlas Research Network.

Cell. 2015 Nov 5;163(4):1011-25. doi: 10.1016/j.cell.2015.10.025.

PMID:
26544944
5.

Transcriptome Profiling of Pediatric Core Binding Factor AML.

Hsu CH, Nguyen C, Yan C, Ries RE, Chen QR, Hu Y, Ostronoff F, Stirewalt DL, Komatsoulis G, Levy S, Meerzaman D, Meshinchi S.

PLoS One. 2015 Sep 23;10(9):e0138782. doi: 10.1371/journal.pone.0138782. eCollection 2015.

6.

Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells.

Levina E, Ji H, Chen M, Baig M, Oliver D, Ohouo P, Lim CU, Schools G, Carmack S, Ding Y, Broude EV, Roninson IB, Buttyan R, Shtutman M.

Oncotarget. 2015 May 30;6(15):13088-104.

7.

Integrative clinical genomics of advanced prostate cancer.

Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, Montgomery B, Taplin ME, Pritchard CC, Attard G, Beltran H, Abida W, Bradley RK, Vinson J, Cao X, Vats P, Kunju LP, Hussain M, Feng FY, Tomlins SA, Cooney KA, Smith DC, Brennan C, Siddiqui J, Mehra R, Chen Y, Rathkopf DE, Morris MJ, Solomon SB, Durack JC, Reuter VE, Gopalan A, Gao J, Loda M, Lis RT, Bowden M, Balk SP, Gaviola G, Sougnez C, Gupta M, Yu EY, Mostaghel EA, Cheng HH, Mulcahy H, True LD, Plymate SR, Dvinge H, Ferraldeschi R, Flohr P, Miranda S, Zafeiriou Z, Tunariu N, Mateo J, Perez-Lopez R, Demichelis F, Robinson BD, Schiffman M, Nanus DM, Tagawa ST, Sigaras A, Eng KW, Elemento O, Sboner A, Heath EI, Scher HI, Pienta KJ, Kantoff P, de Bono JS, Rubin MA, Nelson PS, Garraway LA, Sawyers CL, Chinnaiyan AM.

Cell. 2015 May 21;161(5):1215-28. doi: 10.1016/j.cell.2015.05.001. Erratum in: Cell. 2015 Jul 16;162(2):454.

PMID:
26000489
8.

RNA sequencing reveals differentially expressed genes as potential diagnostic and prognostic indicators of gallbladder carcinoma.

Gu X, Li B, Jiang M, Fang M, Ji J, Wang A, Wang M, Jiang X, Gao C.

Oncotarget. 2015 Aug 21;6(24):20661-71.

9.

Discovery and Classification of Fusion Transcripts in Prostate Cancer and Normal Prostate Tissue.

Luo JH, Liu S, Zuo ZH, Chen R, Tseng GC, Yu YP.

Am J Pathol. 2015 Jul;185(7):1834-45. doi: 10.1016/j.ajpath.2015.03.008. Epub 2015 May 9. Review.

PMID:
25963990
10.

Functional characterization of BC039389-GATM and KLK4-KRSP1 chimeric read-through transcripts which are up-regulated in renal cell cancer.

Pflueger D, Mittmann C, Dehler S, Rubin MA, Moch H, Schraml P.

BMC Genomics. 2015 Mar 27;16:247. doi: 10.1186/s12864-015-1446-z.

11.

CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities.

Terry S, El-Sayed IY, Destouches D, Maillé P, Nicolaiew N, Ploussard G, Semprez F, Pimpie C, Beltran H, Londono-Vallejo A, Allory Y, de la Taille A, Salomon DS, Vacherot F.

Oncotarget. 2015 May 20;6(14):11994-2008.

12.

Genomic rearrangements in prostate cancer.

Barbieri CE, Rubin MA.

Curr Opin Urol. 2015 Jan;25(1):71-6. doi: 10.1097/MOU.0000000000000129. Review.

13.

NF-κB, an active player in human cancers.

Xia Y, Shen S, Verma IM.

Cancer Immunol Res. 2014 Sep;2(9):823-30. doi: 10.1158/2326-6066.CIR-14-0112. Review.

14.

Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.

Wyatt AW, Mo F, Wang K, McConeghy B, Brahmbhatt S, Jong L, Mitchell DM, Johnston RL, Haegert A, Li E, Liew J, Yeung J, Shrestha R, Lapuk AV, McPherson A, Shukin R, Bell RH, Anderson S, Bishop J, Hurtado-Coll A, Xiao H, Chinnaiyan AM, Mehra R, Lin D, Wang Y, Fazli L, Gleave ME, Volik SV, Collins CC.

Genome Biol. 2014 Aug 26;15(8):426. doi: 10.1186/s13059-014-0426-y.

15.

Transcriptome analysis reveals a dynamic and differential transcriptional response to sulforaphane in normal and prostate cancer cells and suggests a role for Sp1 in chemoprevention.

Beaver LM, Buchanan A, Sokolowski EI, Riscoe AN, Wong CP, Chang JH, Löhr CV, Williams DE, Dashwood RH, Ho E.

Mol Nutr Food Res. 2014 Oct;58(10):2001-13. doi: 10.1002/mnfr.201400269. Epub 2014 Aug 5.

16.

The IncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer.

Prensner JR, Sahu A, Iyer MK, Malik R, Chandler B, Asangani IA, Poliakov A, Vergara IA, Alshalalfa M, Jenkins RB, Davicioni E, Feng FY, Chinnaiyan AM.

Oncotarget. 2014 Mar 30;5(6):1434-8.

17.

TRAF2 is an NF-κB-activating oncogene in epithelial cancers.

Shen RR, Zhou AY, Kim E, O'Connell JT, Hagerstrand D, Beroukhim R, Hahn WC.

Oncogene. 2015 Jan 8;34(2):209-16. doi: 10.1038/onc.2013.543. Epub 2013 Dec 23.

18.

Identification of molecular tumor markers in renal cell carcinomas with TFE3 protein expression by RNA sequencing.

Pflueger D, Sboner A, Storz M, Roth J, Compérat E, Bruder E, Rubin MA, Schraml P, Moch H.

Neoplasia. 2013 Nov;15(11):1231-40.

19.

Exploration of the gene fusion landscape of glioblastoma using transcriptome sequencing and copy number data.

Shah N, Lankerovich M, Lee H, Yoon JG, Schroeder B, Foltz G.

BMC Genomics. 2013 Nov 22;14:818. doi: 10.1186/1471-2164-14-818.

20.

Early detection of clinically significant prostate cancer at diagnosis: a prospective study using a novel panel of TMPRSS2:ETS fusion gene markers.

Chan SW, Nguyen PN, Violette P, Brimo F, Taguchi Y, Aprikian A, Chen JZ.

Cancer Med. 2013 Feb;2(1):63-75. doi: 10.1002/cam4.49. Epub 2013 Feb 3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk